首页 | 本学科首页   官方微博 | 高级检索  
     

3种根除幽门螺杆菌方案的疗效比较
引用本文:汤瑾,孙吉,史燕敏,蔡维. 3种根除幽门螺杆菌方案的疗效比较[J]. 中国医院用药评价与分析, 2013, 0(5): 456-458
作者姓名:汤瑾  孙吉  史燕敏  蔡维
作者单位:上海市岳阳中西医结合医院消化内科,上海200437
摘    要:目的:评价三联疗法、四联疗法和序贯疗法根除幽门螺杆菌(Hp)的疗效。方法:将经胃镜检查确诊为慢性胃炎和消化性溃疡且Hp阳性的240例患者以随机抽样法分为3组,三联疗法组(雷贝拉唑+阿莫西林+克拉霉素)、四联疗法组(雷贝拉唑+阿莫西林+克拉霉素+胶体果胶铋)和序贯疗法组(前5 d使用雷贝拉唑+阿莫西林,后5 d使用雷贝拉唑+克拉霉素+甲硝唑),治疗结束停药4周后行14C-尿素呼气试验复查,比较3组Hp根除率。结果:(1)三联疗法组、四联疗法组和序贯疗法组按意向治疗(ITT)分析其Hp根除率分别为73.75%、92.5%和81.25%,3组按方案治疗(PP)分析其Hp根除率分别为77.63%、93.67%和83.33%,2种分析方法比较,四联疗法组Hp根除率优于三联疗法组和序贯疗法组,差异有统计学意义(P〈0.05);三联疗法组与序贯疗法组Hp根除率差异无统计学意义(P〉0.05)。(2)三联疗法组、四联疗法组和序贯疗法组成本-效果比按ITT分析分别为1.75、1.57和1.79,按PP分析分别为1.67、1.55和1.65。结论:根除Hp四联疗法是一种高效、安全、经济的治疗方案。

关 键 词:三联疗法  四联疗法  序贯疗法  幽门螺杆菌  根除率

Eradication Efficacy of Three Therapeutic Regimens for Helicobacter Pylori
TANG Jin,SUN Ji,SHI Yan-min,CAI Wei. Eradication Efficacy of Three Therapeutic Regimens for Helicobacter Pylori[J]. Evaluation and Analysis of Drug-Use in Hospital of China, 2013, 0(5): 456-458
Authors:TANG Jin  SUN Ji  SHI Yan-min  CAI Wei
Affiliation:( Dept. of Digestive Diseases, Shanghai Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai 200437, China)
Abstract:OBJECTIVE:To evaluate the eradication efficacy of triple therapy, quadruple therapy and sequential therapy for helicobacter pylori (Hp). METHODS: 240 patients with Hp infection who had diagnosed by gastroscopy as having chronic gastritis and peptic ulcer were randomly assigned to the triple therapy group (rabeprazole + amoxicillin + clarithromycin), quadruple therapy group (rabeprazole + amoxicillin + clarithromycin + colloidal bismuth pectin) or sequential therapy group (rabepazole + amoxicillin for the first 5 days, followed by rabepazole + clarithromycin + metronidazole for second 5 days). After drug withdrawal of 4 weeks, 14 C-urea breath test was performed to compare the Hp eradication rate among the 3 groups. RESULTS:( 1 )Intention-to-treat (ITT) analysis revealed eradication rates of 73.75% , 92.5% and 81.25% , respectively in triple therapy group, quadruple therapy group and sequential therapy; per-protocol (PP) analysis revealed Hp eradication rates of 77.63%, 93.67% and 83.33%, respectively; comparedby the ITT analysis and PP analysis, quadruple therapy was better than both triple therapy and sequential therapy in terms of Hp eradication rate and the differences were significant ( P 〈 0. 05 ), yet no significant difference was noted between triple therapy and sequential therapy. (2) ITF analysis revealed cost-effectiveness ratios ofl. 75, 1.57 and 1.79, respectively in triple therapy, quadruple therapy and sequential therapy groups; PP analysis revealed cost- effectiveness ratios of 1.67, 1.55 and 1.65, respectively. CONCLUSION : The quadruple therapy was proved to be an effective, safe and economical regimen for Hp eradication.
Keywords:Triple therapy  Quadruple therapy  Sequential therapy  Helicobacter pylori  Eradication rate
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号